肺腺癌中KEAP1突变促进免疫逃避和免疫疗法耐药性
Anastasia-Maria Zavitsanou1, Ray Pillai2, Yuan Hao3
1Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA; Vilcek Institute of Graduate Biomedical Sciences, NYU Grossman School of Medicine, New York, NY, USA.
肺癌中的KEAP1突变通过抑制免疫细胞来阻碍免疫疗法. 将谷氨酸酶抑制与免疫检查点阻塞相结合可以克服这种抵抗,为KEAP1突变肺腺癌提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症遗传学 癌症遗传学
背景情况:
- 免疫疗法在肺癌治疗方面取得了先进的进展.
- 在肺腺癌中常见的KEAP1突变往往导致免疫治疗失败.
研究的目的:
- 研究KEAP1突变如何影响瘤免疫微环境并驱动免疫疗法耐药性.
- 确定治疗策略,以克服KEAP1突变肺癌中的耐药性.
主要方法:
- 为KEAP1突变瘤建立了抗原肺癌模型.
- 利用单细胞技术和耗尽研究.
- 采用了CRISPR-Cas9基因向的方法.
- 分析了患者样本.
主要成果:
- KEAP1突变减少树突细胞和T细胞的反应,导致免疫疗法耐药性.
- 过度激活NRF2抗氧化途径在KEAP1突变瘤中调解免疫抑制.
- 氨酸酶抑制和免疫检查点阻塞的联合治疗逆转了免疫抑制.
结论:
- KEAP1突变通过NRF2通路激活促进肺癌中的免疫逃避.
- 准NRF2通路和结合疗法可以恢复免疫治疗的敏感性.
- 这项研究为KEAP1突变肺癌提供了新的治疗途径.
更多相关视频
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
相关概念视频
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Mitogens and the Cell Cycle
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
